Newsletter | January 20, 2025

01.20.25 -- Unlocking The Potential Of AI In Pharma

FEATURED ARTICLE

Unlocking The Potential Of AI In Pharma: The Power Of Data Systems

Clean, humanized data and data systems are the crucial fuel for engines driving new AI capabilities and uses across the biopharmaceutical industry. Data integrity, accessibility, and ethical use of data are prerequisites for turning data systems and AI into trusted allies.

INDUSTRY INSIGHTS

Implementing ICH E6 (R3) In A Risk Averse Culture

Get several pointers on how to facilitate a transition to an agile, multi-faceted, and continuous risk and issue management approach aligned with the Statistical Analysis Plan.

The Write Side Of AI: Augmenting Capabilities, Not Replacing Them

AI applications in medical writing are in their infancy, and the technology suffers several shortcomings including plagiarism, copyright infringement, and misinformation dissemination.

Evolving Into Biopharma 4.0: A Stepwise Journey Of Digital Transformation

You don’t need to make huge investments to shorten time-to-market using digitalization, intelligent automation, or AI. Find out how to transform your process with well-planned incremental steps.

Accelerating The Development And Production Of High-Quality bsAbs

Bispecific antibodies (bsAbs) are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn about an innovative platform offering excellent pairing and enhanced productivity.

Nurturing Innovation In Drug Development

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.